Mural Oncology plc (MURA) Financials

$4.05

south_east
-$0.17 (-4.03%)
Day's range
$4.02
Day's range
$4.24
$0$0-$50M-$50M-$100M-$100M-$150M-$150M-$200M-$200M-$250M-$250MEarning2021202120222022202320235%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

MURA Income statement / Annual

Last year (2023), Mural Oncology plc's total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Mural Oncology plc's net income was -$207.45 M. See Mural Oncology plc,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021
Period Ended 12/31/2023 12/31/2022 12/31/2021
Operating Revenue $0.00 $0.00 $0.00
Cost of Revenue $2.57 M $1.54 M $1.47 M
Gross Profit -$2.57 M -$1.54 M -$1.47 M
Gross Profit Ratio 0 0 0
Research and Development Expenses $162.03 M $170.07 M $159.82 M
General & Administrative Expenses $30.71 M $25.08 M $15.55 M
Selling & Marketing Expenses -$667,000.00 $0.00 $0.00
Selling, General & Administrative Expenses $30.04 M $25.08 M $15.55 M
Other Expenses $0.00 $0.00 $0.00
Operating Expenses $192.07 M $195.15 M $175.37 M
Cost And Expenses $194.64 M $195.15 M $175.37 M
Interest Income $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00
Depreciation & Amortization $2.57 M $1.54 M $1.47 M
EBITDA -$192.72 M -$183.38 M -$173.89 M
EBITDA Ratio 0 0 0
Operating Income Ratio 0 0 0
Total Other Income/Expenses Net -$649,000.00 $10.22 M $0.00
Income Before Tax -$195.29 M -$195.15 M -$175.37 M
Income Before Tax Ratio 0 0 0
Income Tax Expense $12.16 M $4.88 M $68,000.00
Net Income -$207.45 M -$200.03 M -$175.43 M
Net Income Ratio 0 0 0
EPS -12.43 -11.99 -10.51
EPS Diluted -12.43 -11.99 -10.51
Weighted Average Shares Out $16.69 M $16.69 M $16.69 M
Weighted Average Shares Out Diluted $16.69 M $16.69 M $16.69 M
Link